hotspot -WSS

hotspot

author：hotspot 2025-09-02 22:06:09 - browse：4

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： The surgeon had a dilemma only a Nazi medical text could resolve

WSS

Francis Collins on trust in science and how Covid communications failed

Resistance to opioid

The surgeon had a dilemma only a Nazi medical text could resolve

Latigo launches with $135 million for Vertex

My yearlong odyssey to get my son’s ADHD medication covered

Prior authorization will have to move faster under new Biden rule

Wikipedia

hotspot

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Having children helps parents live longer, especially after age 80

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New brain studies show LSD's effects on the brain in full color

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Juul documents reveal insider tactics on political lobbying

As demand for Covid shots wanes, Moderna seeks its next success

Humana cuts profit projections as Medicare Advantage costs soar

Moonlake's readout produced a cash windfall. Risks remain

Study gives hint on South Asians’ higher risk of cardiovascular disease

knowledge

Having children helps parents live longer, especially after age 80

Think you might have Covid

Congress must protect the remaining independent doctors

Having children helps parents live longer, especially after age 80

Bernie Sanders gets little from pharma CEOs on drug prices

Eli Lilly, Pfizer, and others want in on the online prescription market

entertainment

knowledge

Wikipedia

leisure time